San Luis Obispo County assemblyman won’t run for reelection
Assemblyman Jordan Cunningham, a Republican who represents San Luis Obispo County and northern Santa Barbara County in Sacramento, announced Jan. 13 that he will not seek reelection in the fall. Cunningham has represented the 35th District in the California Assembly since 2016. He won reelection in 2018 and 2020. Under California’s term limits law, he Read More →
Rubicon Theatre gets biggest donation ever, will buy visiting artists’ residence
Rubicon Theatre Company, a professional company in Ventura, has received the biggest donation in its history, some of which will go to buy a four-unit residential property to house visiting artists and performers, the company announced Jan. 11. The gifts total $2.3 million, and come from Karyn Jackson of Arcadia, a former Ventura resident; her Read More →
Inogen shares drop despite projected revenue growth
Goleta-based Inogen expects minor revenue growth in the fourth quarter of 2021 but major growth for the full fiscal year, according to preliminary estimates the company released Jan. 10. The portable oxygen concentrator manufacturer expects to see revenue in the range of $75.9 million to $76.9 million for the three months ended December 31, growth Read More →
Limoneira reports growing revenue and shrinking losses for Q4
Limoneira ended its 2020-21 fiscal year on a strong note, with growing revenue and shrinking losses in the fourth quarter, the Santa Paula-based agribusiness announced Jan. 10. Limoneira — a grower and seller of lemons, avocados and other fruits and also a real estate developer — generated $33.5 million in revenue during the fourth quarter Read More →
Sientra shares up after company releases 2021 revenue estimates
The Goleta-based breast implant manufacturer Sientra expects growth in the fourth quarter of 2021 and estimates its “highest-ever breast products yearly revenue” of up to $81 million for the full year, the company said Jan. 10. Sientra reported that its preliminary unaudited revenue from operations for the fourth quarter of 2021 is expected to be Read More →
Amgen inks drug development deal worth up to $1.9B
Thousand Oaks-based Amgen has reached an agreement with Generate Biomedicines, a Massachusetts-based therapeutics company, to research, discover and create protein therapeutics, the company announced Jan. 6. According to the agreement, Amgen, one of the largest biotech companies in the world, will pay $50 million up front to fund the initial five programs, with a potential Read More →
Capsida’s new CEO hopes success is in the genes
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
